Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide in actinic prurigo.

C R Lovell, J L Hawk, C D Calnan

    The British Journal of Dermatology
    |April 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2018
    Same author

    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.

    The British journal of dermatology·2018
    Same author

    Localization of the Chloroperoxidase of the Capitellid Polychaete Notomastus lobatus.

    The Biological bulletin·2017
    Same author

    Morphoea profunda and its relationship to eosinophilic fasciitis.

    Clinical and experimental dermatology·2017
    Same author

    Porphyria and Photosensitivity.

    Indian journal of dermatology and venereology·2017
    Same author

    Actinic Reticuloid.

    Indian journal of dermatology and venereology·2017
    Same journal

    Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

    The British journal of dermatology·2026
    Same journal

    Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

    The British journal of dermatology·2026
    Same journal

    Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

    The British journal of dermatology·2026
    Same journal

    Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

    The British journal of dermatology·2026
    Same journal

    Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

    The British journal of dermatology·2026
    Same journal

    Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

    The British journal of dermatology·2026
    See all related articles

    Thalidomide effectively treats actinic prurigo, with most patients experiencing lasting symptom relief. Careful use with contraception is advised for women of childbearing age due to potential risks.

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Actinic prurigo is a severe, chronic photodermatosis causing intense itching and skin lesions.
    • Current treatments for actinic prurigo offer limited efficacy and can have significant side effects.

    Purpose of the Study:

    • To evaluate the efficacy and safety of thalidomide in patients with actinic prurigo.

    Main Methods:

    • A cohort of fourteen patients diagnosed with actinic prurigo received thalidomide treatment.
    • Patient outcomes, including symptom improvement and side effects, were monitored.

    Main Results:

    • Eleven out of fourteen patients (78.6%) demonstrated sustained clinical improvement with thalidomide.
    • Three patients remained symptom-free after cessation of the drug.

    Related Experiment Videos

  • No major adverse events were reported during the study.

    • Conclusions:

    • Thalidomide is a highly effective therapeutic option for managing actinic prurigo.
    • The drug's use necessitates strict adherence to contraception measures for women of childbearing potential to mitigate teratogenic risks.